Patents by Inventor Silvia Lenzini

Silvia Lenzini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHIC COMPOUNDS AND USES THEREOF
    Publication number: 20240018091
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Application
    Filed: May 30, 2023
    Publication date: January 18, 2024
    Inventor: Silvia LENZINI
  • Polymorphic compounds and uses thereof
    Patent number: 11697633
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: July 11, 2023
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventor: Silvia Lenzini
  • POLYMORPHIC COMPOUNDS AND USES THEREOF
    Publication number: 20220371985
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Application
    Filed: May 5, 2022
    Publication date: November 24, 2022
    Inventor: Silvia LENZINI
  • Polymorphic compounds and uses thereof
    Patent number: 11345654
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: May 31, 2022
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventor: Silvia Lenzini
  • POLYMORPHIC COMPOUNDS AND USES THEREOF
    Publication number: 20200131114
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Application
    Filed: October 24, 2019
    Publication date: April 30, 2020
    Inventor: Silvia Lenzini